Advertisement

Topics

Aclaris Therapeutics to Announce Second Quarter 2016 Financial Results on August 11, 2016

20:00 EDT 1 Aug 2016 | Globe Newswire

MALVERN, Pa., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage specialty pharmaceutical company, will release its second quarter financial results before the market opens on Thursday, August 11, 2016.

Management will conduct a conference call at 8:30 a.m. ET that day to discuss the Company’s financial results and provide a general business update.  The conference will be webcast live over the Internet and can be accessed by logging on to the “Investors” section of the Aclaris Therapeutics website, www.aclaristx.com, prior to the event.  A replay of the webcast will be archived on the Company’s website for 30 days following the call.

To participate on the live call, please dial (844) 776-7782 (domestic) or (661) 378-9535 (international), and reference conference ID 47292324 prior to the start of the call. 

About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company focused on identifying, developing, and commercializing innovative and differentiated drugs to address significant unmet needs in dermatology.  Aclaris is based in Malvern, Pennsylvania and more information can be found by visiting Aclaris’ website at www.aclaristx.com

Contact:

Aclaris Contact
Michael Tung, M.D. 
Investor Relations
484-329-2140
mtung@aclaristx.com

Media Contact
Mariann Caprino
TogoRun
917-242-1087
M.Caprino@togorun.com

Primary Logo

NEXT ARTICLE

More From BioPortfolio on "Aclaris Therapeutics to Announce Second Quarter 2016 Financial Results on August 11, 2016"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...